Although there is evidence that human neoplastic lesions of thyroid C cells express the GLP-1R [72], robust data on a connection between the risk of MTC and the use of GLP-1 RAs in humans are currently unavailable. This evidence concerns the gene GLP1R and medullary thyroid gland carcinoma.